Skip to main content
Equibles
SRRK logo

SRRK · Scholar Rock Holding Corp

Track SRRK — free

Use SRRK with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$55.37 -0.57 (-1.02%)
Russell 2000 member Rebalance outlook locked
Market Cap
$6.81B
Shares
121.79M

SRRK metrics

56 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$55.94
Market cap
$6.81B

Price action

19 metrics
Price change (1W)
-6.6%
Price change (30D)
+17.4%
Price change (3M)
+25.7%
Price change (6M)
+18.3%
Price change (YTD)
+27.4%
Price change (1Y)
+69.4%
Trailing year
Price change (5Y)
+44.6%
52-week high
$60.04
52-week low
$27.92
Change from 52-week high
-6.6%
Change from 52-week low
+100.9%
Annualized volatility
60.4%
Beta
1.0
RSI (14D)
54.8
Price vs SMA 50
+5.2%
Price vs SMA 200
+18.0%
Avg volume (3M)
1.31M
Relative volume
0.8
Average dollar volume
$68.06M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
121.79M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
27.0
reciprocal yield 3.7%
FCF yield
-4.3%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-6.0%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
35.0×
reciprocal yield 2.9%
EV / revenue historical average (5Y)
35.0×
reciprocal yield 2.9%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
−$406.36M
Net income (TTM)
−$408.59M
Trailing 12 months
Diluted EPS (TTM)
$-3.31
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-13.48

Growth

11 metrics
Revenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
$0
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+15.9%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-161.0%
Return on assets
-78.0%
Debt / equity
—
Current ratio
7.0
EBITDA (TTM)
−$404.88M
Free cash flow (TTM)
−$297.01M
Quick ratio
7.0
Interest coverage
-38.0
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$437.09M
Total assets
$523.54M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$296.83M
Capital expenditures (TTM)
$185,000
R&D (TTM)
$207.41M
SG&A (TTM)
—
Stock compensation (TTM)
$75.66M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
308
13F filer change QoQ
+27
Institutional ownership
114.3%

Short interest

3 metrics
Short interest
15.0%
Latest settlement · 19.8 days to cover
Days to cover
19.8d
Short-squeeze score
84 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$923,084
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1727196 CUSIP 80706P103 13F (30d) 236 filings 235 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)